| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Lorazepam measurement |
Component |
True |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Lorazepam-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Accidental lorazepam poisoning |
Causative agent (attribute) |
False |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Intentional lorazepam poisoning |
Causative agent (attribute) |
False |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| intoxication par le lorazépam d'intention indéterminée |
Causative agent (attribute) |
False |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Lorazepam adverse reaction (disorder) |
Causative agent (attribute) |
True |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Allergy to lorazepam |
Causative agent (attribute) |
False |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lorazepam overdose |
Causative agent (attribute) |
True |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Accidental lorazepam overdose |
Causative agent (attribute) |
True |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Intentional lorazepam overdose |
Causative agent (attribute) |
True |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| surdose de lorazépam d'intention indéterminée |
Causative agent (attribute) |
False |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Lorazepam [anxiolytic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely lorazepam 1 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lorazepam 2.5mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lorazepam [epilepsy] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lorazepam [anesthesia] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing lorazepam in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Parenteral lorazepam |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Lorazepam 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lorazepam 500 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lorazepam 4mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lorazepam 2mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Poisoning by lorazepam |
Causative agent (attribute) |
True |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Lorazepam 2mg/mL injection solution 2mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lorazepam 4mg/mL injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lorazepam 2mg/mL injection solution 0.5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lorazepam 2mg/mL injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lorazepam 2mg/mL injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lorazepam 4mg/mL injection solution 2mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lorazepam 4mg/mL injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| lorazépam 4 mg/1 mL, pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Intentional lorazepam poisoning |
Causative agent (attribute) |
True |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Accidental poisoning by lorazepam |
Causative agent (attribute) |
True |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Allergy to lorazepam |
Causative agent (attribute) |
True |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely lorazepam 1 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely lorazepam 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Lorazepam 2.5mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Lorazepam 2.5mg tablet (substance) |
Has basis of strength substance (attribute) |
True |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Lorazepam 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Lorazepam 2 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Lorazepam 500 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Lorazepam 500 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Lorazepam 2 mg oral tablet |
Has precise active ingredient |
True |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Lorazepam 500 microgram oral tablet |
Has precise active ingredient |
True |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely lorazepam 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Lorazepam 2.5mg tablet (substance) |
Has precise active ingredient |
True |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely lorazepam 4 milligram/1 milliliter conventional release solution for injection ampule |
Has basis of strength substance (attribute) |
False |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely lorazepam 4 milligram/1 milliliter conventional release solution for injection ampule |
Has precise active ingredient |
False |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Lorazepam only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Lorazepam only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only lorazepam in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Lorazepam 4 mg/mL solution for injection |
Has precise active ingredient |
True |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Lorazepam 4 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Lorazepam 2 mg/mL solution for injection |
Has precise active ingredient |
True |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Lorazepam 2 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Lorazepam (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]